Future directions for medicinal chemistry in the field of oligonucleotide therapeutics
RNA · 2023-04 · 29 (4) · 423-433
DOI: 10.1261/rna.079511.122 ↗Kurz gefasst
Fachartikel in der Zeitschrift RNA, online erschienen am 24.01.2023. Verfasst von Jonathan Hall. Beteiligte Einrichtung: Institute of Pharmaceutical Sciences, Department of Chemistry and Applied Biosciences, ETH Zurich, 8093 Zurich, Switzerland jonathan.hall@pharma.ethz…. Hauptthemen laut MEDLINE: Oligonucleotides, Chemistry, Pharmaceutical. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 95 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCCR RNA and Disease and the Swiss National Science Foundation.
Abstract (Originalsprache)
In the last decade, the field of oligonucleotide therapeutics has matured, with the regulatory approval of several single-stranded and double-stranded RNA drugs. In this Perspective, I discuss enabling developments and likely future directions in the field from the perspective of oligonucleotide chemistry.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Institute of Pharmaceutical Sciences, Department of Chemistry and Applied Biosciences, ETH Zurich, 8093 Zurich, Switzerland jonathan.hall@pharma.ethz.ch.
Förderung
- NCCR RNA and Disease and the Swiss National Science Foundation
Zitieren
APA
Hall, J. (2023). Future directions for medicinal chemistry in the field of oligonucleotide therapeutics. RNA, 29(4), 423-433. https://doi.org/10.1261/rna.079511.122
Vancouver
Hall J. Future directions for medicinal chemistry in the field of oligonucleotide therapeutics. RNA. 2023;29(4):423-433. doi:10.1261/rna.079511.122
BibTeX
@article{Hall2023,
author = {Hall, Jonathan},
title = {Future directions for medicinal chemistry in the field of oligonucleotide therapeutics},
journal = {RNA},
year = {2023},
volume = {29},
number = {4},
pages = {423--433},
doi = {10.1261/rna.079511.122}
}
EUVIMED